Nitric oxide-induced downregulation of cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells

Circulation

Volumn 97, Issue 20, 1998, Pages 2066-2072

  Guo, Kun ^a   Andres, Vicente ^a   Walsh, Kenneth ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Genes; Muscle, smooth; Nitric oxide

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN E; MITOGEN ACTIVATED PROTEIN KINASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CELL ACTIVITY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IMMUNOBLOTTING; INTIMA; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER;

EID: 0032568481     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.20.2066     Document Type: Article

References (43)

1. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Hriuchi H, Ohishi H. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol. 1988;12:616-623.
2. Serruys P, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy J, Van den Heuvel P, Delcan J, Morel MA, Benestent Group. A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
3. Fischman DL, Leon MD, Baim DS, Shatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:469-501.
4. Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Salter LF, Popma JJ, Wong SC, Leon MB. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol. 1995;26:720-724.
5. Dilley RJ, McGeachie JK, Prendergast FJ. A review of the histologic changes in vein-to-artery grafts, with particular reference to intimal hyperplasia. Arch Surg. 1988;123:691-696.
6. Moncada S, Palmer RMJ, Higgs EA. NO: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
7. Garg UC, Hassid A. Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells. Eur J Pharmacol. 1993;237:243-249.
8. von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995;92:1137-1141.
9. Schwarzacher SP, Lim TT, Wang B, Kemoff RS, Neibauer J, Cooke JP, Yeung AC. Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation. 1997;95:1863-1869.
10. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invent. 1992;90:1168-1172.
11. Wang B, Singer A, Tsao PS, Drexler H, Kosek J, Cooke JP. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J Am Coll Cardiol. 1994;23:452-458.
12. McNamara DB, Bedi B, Aurora H, Tena L, Ignarro LJ, Kadowitz PJ, Akers DL. L-Arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun. 1993;193:291-296.
13. Hamon M, Vallet B, Bauters C, Wernert N, McFadden EP, Lablanche J, Dupuis B, Bertrand ME. Long-term oral administration of L-arginine reduces intimai thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation. 1994; 90:1357-1362.
14. Sherr CJ. G1 phase progression: cycling on cue. Cell. 1994;79:551-555.
15. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-330.
16. Ohtsubo M, Theodoras AM, Schumachter J, Roberts JM. Human cyclin, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol. 1995;15:2612-2624.
17. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 1992;70:993-1006.
18. Ohtsubo M, Roberts JM. Cyclin-dependent regulation of G1 in mammalian flbroblasts. Science. 1993;259:1908-1912.
19. Resnicky D, Gossen M, Bujard H, Reed S. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol. 1994;14:1669-1679.
20. Zindy F, Lamas E, Chenivesse X, Sobczak J, Wang J, Fesquet D, Henglein B, Brechet C. Cyclin A is required in S phase in normal epithelial cells. Biochem Biophys Res Commun. 1992;182:1144-1154.
21. Pagano M, Pepperkok R, Verde F, Ansorge W, Dreatta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 1992;11: 961-971.
22. Girard F, Strausfeld U, Fernandez A, Lamb NJ. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell. 1991;67: 1169-1179.
23. Jackson PK, Chevalier S, Philippe M, Kirschner MW. Early events in DNA replication require cyclin E and are blocked by p21CIP1. J Cell Biol. 1995;130:755-769.
24. Wei GL, Krasinski K, Kearney M, Isner JM, Walsh K, Andrés V. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ Res. 1997;80:418-426.
25. Abe J, Zhou W, Taguchi J, Takuwa N, Miki K, Okazaki H, Kurokawa K, Kumada M, Takuwa Y. Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery. Biochem Biophys Res Commun. 1994;198:16-24.
26. Morishita R, Gibbons GH, Ellison KE, Nukajima M, von der Leynen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest. 1994;93:1458-1464.
27. Mader SL. Influence of animal age on the β-adrenergic system in cultured rat aortic and mesenteric artery smooth muscle cells. J Gerontol Biol Sci. 1992;47:B32-B36.
28. Guo K, Wang J, Andrés V, Smith RC, Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol. 1995;15:3823-3829.
29. Henglein B, Chenivesse X, Wang J, Eick D, Bréchet C. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci U S A. 1994;91:5490-5494.
30. Henthom P, Zervos P, Raducha M, Harris H, Kadesch T. Expression of human placental alkaline phosphatase gene in transfected cells: use as a reporter for studies of gene expression. Proc Natl Acad Sci U S A. 1988; 87:6922-6926.
31. Rothman A, Kulik TJ, Taubman MB, Berk BC, Smith CWJ, Nadal- Ginard B. Development and characterization of a cloned rat pulmonary arterial smooth muscle cell line that maintains differentiated properties through multiple subcultures. Circulation. 1992;86:1977-1986.
32. Andrés V, Fisher S, Wearsch P, Walsh K. Regulation of Gax homeobox gene transcription by a combination of positive factors including MEF2. Mol Cell Biol. 1995;15:4272-4281.
33. Guo K, Walsh K. Inhibition of myogenesis by multiple cyclin/cdk complexes: coordinate regulation of myogenesis and cell cycle activity at the level of E2F. J Biol Chem. 1997;272:791-797.
34. Sarkar R, Gordon D, Stanley JC, Webb RC. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Am J Physiol. 1997;272: H1810-H1818.
35. sdi1/Cip1/Wef1 by nitric oxide-generating vasodilator in vascular smooth muscle cells. J Biol Chem. 1997;272: 10050-10057.
36. Sylvester AM, Chen D, Krasinsky K, Andres V. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. J Clin Invest. 1998;101:940-948.
37. Desdouets C, Matesic G, Molina CA, Foulkes NS, Sassone-Corsi P, Bréchot C, Sobczak-Thépot J. Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol Cell Biol. 1995;15:3301-3309.
38. Yoshizumi M, Hsieh C-M, Zhou F, Tsai J-C, Patterson C, Perrella MA, Lee M-E. The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells. Mol Cell Biol. 1995;15:3266-3272.
39. Schulze A, Zerfass K. Spiekovsky D, Niddendorp S, Berges J, Heiin K, Jansen-Durr P, Henglein B. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci U S A. 1995;92:11264-11268.
40. Desdouets C, Ory C, Matesic G, Soussi T, Bréchot C, Sobczak-Thépot J. ATF-CREB site mediated transcriptional activation and p53 dependent repression of the cyclin A promoter. FEBS Lett. 1996;385:34-38.
41. Barlat I, Henglein B, Plet A, Lamb N, Fernandez A, McKenzie F, Pouysségur J, Vié A, Blanchard JM. TGF-βl and cAMP attenuate cyclin A gene transcription via a cAMP responsive element through independent pathways. Oncogene. 1995;11:1309-1318.
42. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of cdk2 inhibitors. Cell. 1996;87:1069-1078.
43. Smith RC, Branellec D, Gorski DH, Guo K, Perlman H, Dedieu J-F, Pastore C, Mahfoudi A, Denèfle P, Isner JM, Walsh K. p21CIP1- mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 1997;11:1674-1689.